Amitriptyline vs Pantoprazole: side-by-side comparison
Amitriptyline (Tricyclic antidepressant (TCA)) and Pantoprazole (Proton pump inhibitor) belong to different therapeutic classes and are rarely substitutes for each other. The comparison is useful when a single patient is weighing both options for adjacent or overlapping needs.
| Property | Amitriptyline | Pantoprazole |
|---|---|---|
| Therapeutic class | Tricyclic antidepressant (TCA) | Proton pump inhibitor |
| CAS | 50-48-6 | 102625-70-7 |
| ATC | N06AA09 | A02BC02 |
| Molecular weight | 277.40 g/mol | 383.37 g/mol |
| Brands with this active ingredient | 1 | 1 |
What they share
Amitriptyline and Pantoprazole share the common regulatory framework for prescription active ingredients, bioequivalence standards for generics, and pharmacist oversight. Beyond that, points in common are limited.
Key differences
Amitriptyline acts by a different mechanism than Pantoprazole, with indications that barely overlap. Comparing the two is useful when a clinician has mentioned both in the same context or the patient wants to understand why one was prescribed instead of the other.
Mechanisms compared
Amitriptyline: Amitriptyline inhibits the reuptake of serotonin and noradrenaline at central synapses, raising synaptic levels of both neurotransmitters. Pantoprazole: Pantoprazole is a substituted benzimidazole prodrug activated in the acidic environment of the gastric parietal cell, where it irreversibly inhibits the H+/K+-ATPase enzyme — the proton pump responsible for the final ste…
Indications compared
Amitriptyline: Amitriptyline is approved for major depressive disorder, but contemporary use is dominated by low-dose off-label indications: neuropathic pain, fibromyalgia, chronic tension headache, migraine prevention, irritable bowel… Pantoprazole: Pantoprazole is approved in adults and children for the treatment of gastro-oesophageal reflux disease, including erosive oesophagitis healing and maintenance, peptic ulcer disease, prevention of NSAID-induced ulcers, Zo…
Safety profile
Amitriptyline: Common adverse effects reflect anticholinergic, antihistaminic and α1-blocking activity: dry mouth, constipation, urinary hesitancy, blurred vision, sedation, weight gain and orthostatic hypotension. Pantoprazole: Common adverse effects include headache, gastrointestinal symptoms and dizziness.
Frequently asked questions
Is Amitriptyline better than Pantoprazole? ▾
Amitriptyline and Pantoprazole are not "better or worse" — they treat different things. The sensible question is which fits your specific need.
Can Amitriptyline and Pantoprazole be combined? ▾
Whether they can be combined depends on the indications and the interaction profile of each. If both are in a single prescription, the prescriber has weighed it; in self-medication they should never be combined.
Do they have the same side-effect profile? ▾
No — they belong to different classes and have distinct side-effect profiles. Each has its own prescribing information.
Products with Amitriptyline
Products with Pantoprazole
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.